Introduction Prior to 2020, treatment options for multidrug-resistant tuberculosis (MDR-TB) were limited and typically ...

Introduction The Bill and Melinda Gates Foundation (BMGF) has been the World Health Organization’s (WHO) second biggest ...

Introduction There have been increasing concerns about the overproduction of the health workforce in low- and middle-income ...

Introduction Seasonal malaria chemoprevention (SMC) with sulfadoxine-pyrimethamine and amodiaquine (SPAQ) has been delivered ...

Background Stillbirth rates remain unacceptably high in low- and middle-income countries (LMICs). Understanding the causes of ...

Introduction Despite the high rates of intimate partner violence (IPV) globally and the negative impact of IPV and ...

Introduction By 2050, antimicrobial resistance (AMR) could lead to over 10 million deaths annually and $100 trillion in ...

Aiming to investigate small island resilience in public health emergencies, we found existing classifications of Small Island ...

Introduction Tuberculosis (TB) remains an important public health challenge globally. Madagascar faces a substantial TB burden despite enhanced efforts from its national TB control programme. This ...

Primary health care (PHC) is a comprehensive strategy involving the entire society in promoting health. It is an important ...

Introduction Timely detection, notification and response are critical for mitigating outbreak impact, yet evidence linking timeliness to public health outcomes is limited.Methods We hypothesised that ...

Background The combination of bedaquiline, pretomanid, moxifloxacin, and pyrazinamide (BPaMZ) provides the shortest duration of treatment required to sterilize mice in relapsing mouse models.